aluates Reports

$ 0.0

Automative

Global Insomnia Market Insights, Forecast to 2029

Published Date: August 2023

Report Code: QYRE-Auto-37H5901

Global Insomnia Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Insomnia Market Insights, Forecast to 2029

Code: QYRE-Auto-37H5901

Report

August 2023

Pages:94

QYResearch

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Eisai Co Ltd

Meda Consumer Healthcare

Takeda Pharmaceuticals

Pfizer Inc

Sanofi

Vanda Pharmaceuticals

PERNIX Therapeutics

Purdue Pharmaceuticals

Insomnia Market Size

The global Insomnia market is projected to grow from US$ 4152.4 million in 2023 to US$ 5074.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.

Insomnia Market

Insomnia is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood.

Market Analysis and Insights: Global Insomnia Market

Sleep hygiene and lifestyle changes are typically the first treatment for insomnia. Sleep hygiene includes a consistent bedtime, exposure to sunlight, a quiet and dark room, and regular exercise. Cognitive behavioral therapy may be added to this. While sleeping pills may help, they are associated with injuries, dementia, and addiction.

Report Includes

This report presents an overview of global market for Insomnia market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Insomnia, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Insomnia, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insomnia revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Insomnia market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Insomnia revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Merck, Eisai, Meda Consumer Healthcare, Takeda Pharmaceuticals, Pfizer, Sanofi, Vanda Pharmaceuticals, Pernix Therapeutics and Purdue Pharmaceuticals, etc.

Scope of Insomnia Market Report

Report Metric	Details
Report Name	Insomnia Market
Accounted market size in 2023	US$ 4152.4 million
Forecasted market size in 2029	US$ 5074.9 million
CAGR	3.4
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Pharmacological Therapy Non-pharmacological Therapy
Segment by Application	Female Male Senior Citizens
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Eisai, Meda Consumer Healthcare, Takeda Pharmaceuticals, Pfizer, Sanofi, Vanda Pharmaceuticals, Pernix Therapeutics, Purdue Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Insomnia in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insomnia revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Insomnia Market growing?

Ans: The Insomnia Market witnessing a CAGR of 3.4 during the forecast period 2023-2029.

What is the Insomnia Market size in 2029?

Ans: The global Insomnia market is projected to grow from US$ 4152.4 million in 2023 to US$ 5074.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.

Who are the main players in the Insomnia Market report?

Ans: The main players in the Insomnia Market are Merck, Eisai, Meda Consumer Healthcare, Takeda Pharmaceuticals, Pfizer, Sanofi, Vanda Pharmaceuticals, Pernix Therapeutics, Purdue Pharmaceuticals

What are the Application segmentation covered in the Insomnia Market report?

Ans: The Applications covered in the Insomnia Market report are Female, Male, Senior Citizens

What are the Type segmentation covered in the Insomnia Market report?

Ans: The Types covered in the Insomnia Market report are Pharmacological Therapy, Non-pharmacological Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Insomnia Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Pharmacological Therapy

1.2.3 Non-pharmacological Therapy

1.3 Market by Application

1.3.1 Global Insomnia Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Female

1.3.3 Male

1.3.4 Senior Citizens

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Insomnia Market Perspective (2018-2029)

2.2 Global Insomnia Growth Trends by Region

2.2.1 Insomnia Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Insomnia Historic Market Size by Region (2018-2023)

2.2.3 Insomnia Forecasted Market Size by Region (2024-2029)

2.3 Insomnia Market Dynamics

2.3.1 Insomnia Industry Trends

2.3.2 Insomnia Market Drivers

2.3.3 Insomnia Market Challenges

2.3.4 Insomnia Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Insomnia by Players

3.1.1 Global Insomnia Revenue by Players (2018-2023)

3.1.2 Global Insomnia Revenue Market Share by Players (2018-2023)

3.2 Global Insomnia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Insomnia, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Insomnia Market Concentration Ratio

3.4.1 Global Insomnia Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Insomnia Revenue in 2022

3.5 Global Key Players of Insomnia Head office and Area Served

3.6 Global Key Players of Insomnia, Product and Application

3.7 Global Key Players of Insomnia, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Insomnia Breakdown Data by Type

4.1 Global Insomnia Historic Market Size by Type (2018-2023)

4.2 Global Insomnia Forecasted Market Size by Type (2024-2029)

5 Insomnia Breakdown Data by Application

5.1 Global Insomnia Historic Market Size by Application (2018-2023)

5.2 Global Insomnia Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Insomnia Market Size (2018-2029)

6.2 North America Insomnia Market Size by Type

6.2.1 North America Insomnia Market Size by Type (2018-2023)

6.2.2 North America Insomnia Market Size by Type (2024-2029)

6.2.3 North America Insomnia Market Share by Type (2018-2029)

6.3 North America Insomnia Market Size by Application

6.3.1 North America Insomnia Market Size by Application (2018-2023)

6.3.2 North America Insomnia Market Size by Application (2024-2029)

6.3.3 North America Insomnia Market Share by Application (2018-2029)

6.4 North America Insomnia Market Size by Country

6.4.1 North America Insomnia Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Insomnia Market Size by Country (2018-2023)

6.4.3 North America Insomnia Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Insomnia Market Size (2018-2029)

7.2 Europe Insomnia Market Size by Type

7.2.1 Europe Insomnia Market Size by Type (2018-2023)

7.2.2 Europe Insomnia Market Size by Type (2024-2029)

7.2.3 Europe Insomnia Market Share by Type (2018-2029)

7.3 Europe Insomnia Market Size by Application

7.3.1 Europe Insomnia Market Size by Application (2018-2023)

7.3.2 Europe Insomnia Market Size by Application (2024-2029)

7.3.3 Europe Insomnia Market Share by Application (2018-2029)

7.4 Europe Insomnia Market Size by Country

7.4.1 Europe Insomnia Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Insomnia Market Size by Country (2018-2023)

7.4.3 Europe Insomnia Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Insomnia Market Size (2018-2029)

8.2 China Insomnia Market Size by Type

8.2.1 China Insomnia Market Size by Type (2018-2023)

8.2.2 China Insomnia Market Size by Type (2024-2029)

8.2.3 China Insomnia Market Share by Type (2018-2029)

8.3 China Insomnia Market Size by Application

8.3.1 China Insomnia Market Size by Application (2018-2023)

8.3.2 China Insomnia Market Size by Application (2024-2029)

8.3.3 China Insomnia Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Insomnia Market Size (2018-2029)

9.2 Asia Insomnia Market Size by Type

9.2.1 Asia Insomnia Market Size by Type (2018-2023)

9.2.2 Asia Insomnia Market Size by Type (2024-2029)

9.2.3 Asia Insomnia Market Share by Type (2018-2029)

9.3 Asia Insomnia Market Size by Application

9.3.1 Asia Insomnia Market Size by Application (2018-2023)

9.3.2 Asia Insomnia Market Size by Application (2024-2029)

9.3.3 Asia Insomnia Market Share by Application (2018-2029)

9.4 Asia Insomnia Market Size by Region

9.4.1 Asia Insomnia Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Insomnia Market Size by Region (2018-2023)

9.4.3 Asia Insomnia Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Insomnia Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Insomnia Market Size by Type

10.2.1 Middle East, Africa, and Latin America Insomnia Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Insomnia Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Insomnia Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Insomnia Market Size by Application

10.3.1 Middle East, Africa, and Latin America Insomnia Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Insomnia Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Insomnia Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Insomnia Market Size by Country

10.4.1 Middle East, Africa, and Latin America Insomnia Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Insomnia Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Insomnia Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Insomnia Introduction

11.1.4 Merck Revenue in Insomnia Business (2018-2023)

11.1.5 Merck Recent Developments

11.2 Eisai

11.2.1 Eisai Company Details

11.2.2 Eisai Business Overview

11.2.3 Eisai Insomnia Introduction

11.2.4 Eisai Revenue in Insomnia Business (2018-2023)

11.2.5 Eisai Recent Developments

11.3 Meda Consumer Healthcare

11.3.1 Meda Consumer Healthcare Company Details

11.3.2 Meda Consumer Healthcare Business Overview

11.3.3 Meda Consumer Healthcare Insomnia Introduction

11.3.4 Meda Consumer Healthcare Revenue in Insomnia Business (2018-2023)

11.3.5 Meda Consumer Healthcare Recent Developments

11.4 Takeda Pharmaceuticals

11.4.1 Takeda Pharmaceuticals Company Details

11.4.2 Takeda Pharmaceuticals Business Overview

11.4.3 Takeda Pharmaceuticals Insomnia Introduction

11.4.4 Takeda Pharmaceuticals Revenue in Insomnia Business (2018-2023)

11.4.5 Takeda Pharmaceuticals Recent Developments

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Insomnia Introduction

11.5.4 Pfizer Revenue in Insomnia Business (2018-2023)

11.5.5 Pfizer Recent Developments

11.6 Sanofi

11.6.1 Sanofi Company Details

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Insomnia Introduction

11.6.4 Sanofi Revenue in Insomnia Business (2018-2023)

11.6.5 Sanofi Recent Developments

11.7 Vanda Pharmaceuticals

11.7.1 Vanda Pharmaceuticals Company Details

11.7.2 Vanda Pharmaceuticals Business Overview

11.7.3 Vanda Pharmaceuticals Insomnia Introduction

11.7.4 Vanda Pharmaceuticals Revenue in Insomnia Business (2018-2023)

11.7.5 Vanda Pharmaceuticals Recent Developments

11.8 Pernix Therapeutics

11.8.1 Pernix Therapeutics Company Details

11.8.2 Pernix Therapeutics Business Overview

11.8.3 Pernix Therapeutics Insomnia Introduction

11.8.4 Pernix Therapeutics Revenue in Insomnia Business (2018-2023)

11.8.5 Pernix Therapeutics Recent Developments

11.9 Purdue Pharmaceuticals

11.9.1 Purdue Pharmaceuticals Company Details

11.9.2 Purdue Pharmaceuticals Business Overview

11.9.3 Purdue Pharmaceuticals Insomnia Introduction

11.9.4 Purdue Pharmaceuticals Revenue in Insomnia Business (2018-2023)

11.9.5 Purdue Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Merck

Eisai Co Ltd

Meda Consumer Healthcare

Takeda Pharmaceuticals

Pfizer Inc

Sanofi

Vanda Pharmaceuticals

PERNIX Therapeutics

Purdue Pharmaceuticals

List of Tables

Table 1. Global Insomnia Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Pharmacological Therapy

Table 3. Key Players of Non-pharmacological Therapy

Table 4. Global Insomnia Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 5. Global Insomnia Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Insomnia Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Insomnia Market Share by Region (2018-2023)

Table 8. Global Insomnia Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Insomnia Market Share by Region (2024-2029)

Table 10. Insomnia Market Trends

Table 11. Insomnia Market Drivers

Table 12. Insomnia Market Challenges

Table 13. Insomnia Market Restraints

Table 14. Global Insomnia Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Insomnia Revenue Share by Players (2018-2023)

Table 16. Global Top Insomnia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia as of 2022)

Table 17. Global Insomnia Industry Ranking 2021 VS 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Insomnia Revenue (CR5 and HHI) & (2018-2023)

Table 19. Global Key Players of Insomnia, Headquarters and Area Served

Table 20. Global Key Players of Insomnia, Product and Application

Table 21. Global Key Players of Insomnia, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Insomnia Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Insomnia Revenue Market Share by Type (2018-2023)

Table 25. Global Insomnia Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Insomnia Revenue Market Share by Type (2024-2029)

Table 27. Global Insomnia Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Insomnia Revenue Share by Application (2018-2023)

Table 29. Global Insomnia Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Insomnia Revenue Share by Application (2024-2029)

Table 31. North America Insomnia Market Size by Type (2018-2023) & (US$ Million)

Table 32. North America Insomnia Market Size by Type (2024-2029) & (US$ Million)

Table 33. North America Insomnia Market Size by Application (2018-2023) & (US$ Million)

Table 34. North America Insomnia Market Size by Application (2024-2029) & (US$ Million)

Table 35. North America Insomnia Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. North America Insomnia Market Size by Country (2018-2023) & (US$ Million)

Table 37. North America Insomnia Market Size by Country (2024-2029) & (US$ Million)

Table 38. Europe Insomnia Market Size by Type (2018-2023) & (US$ Million)

Table 39. Europe Insomnia Market Size by Type (2024-2029) & (US$ Million)

Table 40. Europe Insomnia Market Size by Application (2018-2023) & (US$ Million)

Table 41. Europe Insomnia Market Size by Application (2024-2029) & (US$ Million)

Table 42. Europe Insomnia Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Europe Insomnia Market Size by Country (2018-2023) & (US$ Million)

Table 44. Europe Insomnia Market Size by Country (2024-2029) & (US$ Million)

Table 45. China Insomnia Market Size by Type (2018-2023) & (US$ Million)

Table 46. China Insomnia Market Size by Type (2024-2029) & (US$ Million)

Table 47. China Insomnia Market Size by Application (2018-2023) & (US$ Million)

Table 48. China Insomnia Market Size by Application (2024-2029) & (US$ Million)

Table 49. Asia Insomnia Market Size by Type (2018-2023) & (US$ Million)

Table 50. Asia Insomnia Market Size by Type (2024-2029) & (US$ Million)

Table 51. Asia Insomnia Market Size by Application (2018-2023) & (US$ Million)

Table 52. Asia Insomnia Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia Insomnia Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 54. Asia Insomnia Market Size by Region (2018-2023) & (US$ Million)

Table 55. Asia Insomnia Market Size by Region (2024-2029) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Insomnia Market Size by Type (2018-2023) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Insomnia Market Size by Type (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Insomnia Market Size by Application (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Insomnia Market Size by Application (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Insomnia Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 61. Middle East, Africa, and Latin America Insomnia Market Size by Country (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Insomnia Market Size by Country (2024-2029) & (US$ Million)

Table 63. Merck Company Details

Table 64. Merck Business Overview

Table 65. Merck Insomnia Product

Table 66. Merck Revenue in Insomnia Business (2018-2023) & (US$ Million)

Table 67. Merck Recent Developments

Table 68. Eisai Company Details

Table 69. Eisai Business Overview

Table 70. Eisai Insomnia Product

Table 71. Eisai Revenue in Insomnia Business (2018-2023) & (US$ Million)

Table 72. Eisai Recent Developments

Table 73. Meda Consumer Healthcare Company Details

Table 74. Meda Consumer Healthcare Business Overview

Table 75. Meda Consumer Healthcare Insomnia Product

Table 76. Meda Consumer Healthcare Revenue in Insomnia Business (2018-2023) & (US$ Million)

Table 77. Meda Consumer Healthcare Recent Developments

Table 78. Takeda Pharmaceuticals Company Details

Table 79. Takeda Pharmaceuticals Business Overview

Table 80. Takeda Pharmaceuticals Insomnia Product

Table 81. Takeda Pharmaceuticals Revenue in Insomnia Business (2018-2023) & (US$ Million)

Table 82. Takeda Pharmaceuticals Recent Developments

Table 83. Pfizer Company Details

Table 84. Pfizer Business Overview

Table 85. Pfizer Insomnia Product

Table 86. Pfizer Revenue in Insomnia Business (2018-2023) & (US$ Million)

Table 87. Pfizer Recent Developments

Table 88. Sanofi Company Details

Table 89. Sanofi Business Overview

Table 90. Sanofi Insomnia Product

Table 91. Sanofi Revenue in Insomnia Business (2018-2023) & (US$ Million)

Table 92. Sanofi Recent Developments

Table 93. Vanda Pharmaceuticals Company Details

Table 94. Vanda Pharmaceuticals Business Overview

Table 95. Vanda Pharmaceuticals Insomnia Product

Table 96. Vanda Pharmaceuticals Revenue in Insomnia Business (2018-2023) & (US$ Million)

Table 97. Vanda Pharmaceuticals Recent Developments

Table 98. Pernix Therapeutics Company Details

Table 99. Pernix Therapeutics Business Overview

Table 100. Pernix Therapeutics Insomnia Product

Table 101. Pernix Therapeutics Revenue in Insomnia Business (2018-2023) & (US$ Million)

Table 102. Pernix Therapeutics Recent Developments

Table 103. Purdue Pharmaceuticals Company Details

Table 104. Purdue Pharmaceuticals Business Overview

Table 105. Purdue Pharmaceuticals Insomnia Product

Table 106. Purdue Pharmaceuticals Revenue in Insomnia Business (2018-2023) & (US$ Million)

Table 107. Purdue Pharmaceuticals Recent Developments

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Insomnia Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Insomnia Market Share by Type: 2022 VS 2029

Figure 3. Pharmacological Therapy Features

Figure 4. Non-pharmacological Therapy Features

Figure 5. Global Insomnia Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 6. Global Insomnia Market Share by Application: 2022 VS 2029

Figure 7. Female Case Studies

Figure 8. Male Case Studies

Figure 9. Senior Citizens Case Studies

Figure 10. Insomnia Report Years Considered

Figure 11. Global Insomnia Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 12. Global Insomnia Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Insomnia Market Share by Region: 2022 VS 2029

Figure 14. Global Insomnia Market Share by Players in 2022

Figure 15. Global Top Insomnia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia as of 2022)

Figure 16. The Top 10 and 5 Players Market Share by Insomnia Revenue in 2022

Figure 17. North America Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 18. North America Insomnia Market Share by Type (2018-2029)

Figure 19. North America Insomnia Market Share by Application (2018-2029)

Figure 20. North America Insomnia Market Share by Country (2018-2029)

Figure 21. United States Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Canada Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe Insomnia Market Size YoY (2018-2029) & (US$ Million)

Figure 24. Europe Insomnia Market Share by Type (2018-2029)

Figure 25. Europe Insomnia Market Share by Application (2018-2029)

Figure 26. Europe Insomnia Market Share by Country (2018-2029)

Figure 27. Germany Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. France Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. U.K. Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Italy Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Russia Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Nordic Countries Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. China Insomnia Market Size YoY (2018-2029) & (US$ Million)

Figure 34. China Insomnia Market Share by Type (2018-2029)

Figure 35. China Insomnia Market Share by Application (2018-2029)

Figure 36. Asia Insomnia Market Size YoY (2018-2029) & (US$ Million)

Figure 37. Asia Insomnia Market Share by Type (2018-2029)

Figure 38. Asia Insomnia Market Share by Application (2018-2029)

Figure 39. Asia Insomnia Market Share by Region (2018-2029)

Figure 40. Japan Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. South Korea Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. China Taiwan Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Southeast Asia Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. India Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Australia Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Insomnia Market Size YoY (2018-2029) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Insomnia Market Share by Type (2018-2029)

Figure 48. Middle East, Africa, and Latin America Insomnia Market Share by Application (2018-2029)

Figure 49. Middle East, Africa, and Latin America Insomnia Market Share by Country (2018-2029)

Figure 50. Brazil Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 51. Mexico Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Turkey Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Saudi Arabia Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Israel Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. GCC Countries Insomnia Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Merck Revenue Growth Rate in Insomnia Business (2018-2023)

Figure 57. Eisai Revenue Growth Rate in Insomnia Business (2018-2023)

Figure 58. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Business (2018-2023)

Figure 59. Takeda Pharmaceuticals Revenue Growth Rate in Insomnia Business (2018-2023)

Figure 60. Pfizer Revenue Growth Rate in Insomnia Business (2018-2023)

Figure 61. Sanofi Revenue Growth Rate in Insomnia Business (2018-2023)

Figure 62. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Business (2018-2023)

Figure 63. Pernix Therapeutics Revenue Growth Rate in Insomnia Business (2018-2023)

Figure 64. Purdue Pharmaceuticals Revenue Growth Rate in Insomnia Business (2018-2023)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions